X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies – Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

Content Team by Content Team
18th November 2024
in Press Statements

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Düsseldorf, Tokyo and Novi – The desire to age in place is stronger than ever, with 95% of adults 55 and older considering it an important goal, according to U.S. News & World Report, even though health challenges often make it difficult. At CES 2025, Asahi Kasei Microdevices (AKM), part of Asahi Kasei Corporation, will unveil a suite of sensor technologies, including millimeter-wave (mmWave) radar and contactless monitoring. These technologies can make AgeTech more reliable and accessible while minimizing intrusion into users’ lives. By providing AI systems with high-quality data, AKM aims to transform how we support and care for seniors, making the expectation of aging in place a safer reality for millions.

“These technologies are designed to be less intrusive and are significantly more accurate than current industry standards,” said Gregg Rouse, President of AKM’s United States business unit. “What sets these components apart is a focus on privacy thanks to our mmWave radar, which presents a new way of monitoring through electromagnetic waves instead of cameras. Our sensors don’t know what you look like, just how you’re doing. AKM’s technology captures essential health indicators as anonymous data points. This allows AI systems to enhance care and safety without infringing on personal privacy and allows users to feel independent.”

Interactive AgeTech Demonstrations

AKM will showcase several live demonstrations at booth 54418 in the Venetian Expo & Convention Center. One such demo is the fall detection system, which recognizes people’s falls, presence, and movement. The system does all this without the use of cameras to offer life-saving monitoring without compromising privacy or independence. This solution uses AKM’s antenna-in-module (AiM) technology, which combines antennas and AKM’s  AK5816 60 GHz mmWave radar transceiver into one unit. Its design provides an easy-to-use, ready-made solution with extremely low noise performance compared to the conventional approach, where antennas are integrated into the device package. A battery-free smart diaper will also be on display. This diaper features a reusable component that enhances elderly and infant care by detecting the presence of liquid, even with a few drops on the electrode. This moisture generates a tiny amount of voltage (~300 mV), which is then amplified by AKM’s AP4470L ultra-low-power boost converter to power the product without batteries or complex electronics. The technology can then wirelessly send data to caregivers using AKM’s AK1595A Bluetooth® Low Energy transmitter, thereby reducing the discomfort associated with prolonged wetness.

AKM will also demonstrate a wristband-based thermometer featuring the AK9757P. This minuscule infrared temperature sensor, measuring just 1.6 x 1.76 mm, integrates seamlessly into wearables such as hearing aids, earbuds, and smartwatches, enabling continuous, non-invasive health monitoring with negligible impact on battery life. It can measure temperature accurately within ±0.2°C even in the presence of a small air gap, allowing for early health issue detection and more personalized care.  Other cutting-edge technologies on display during the convention, will include mmWave radar-based vital sign monitoring (breathing rate, heat rate, heat rate variation, and heartbeat sound), muscle activity monitoring (electromyography) enabled by an analog-front-end IC, and smart home solutions to enhance security and detect air quality.

The Growing Need for Innovative Healthcare Technology

AKM’s innovations represent a significant leap forward in AgeTech and provide invaluable support to caregivers, family members, and patients. By offering real-time, accurate, and AI-ready data, AKM’s technologies can alleviate the stress and uncertainty associated with remote caregiving. Family members can have peace of mind knowing their loved ones are safely monitored. At the same time, professional caregivers can optimize their time and resources, focusing on providing personalized care where it’s needed most. As the population of Americans 65 and older nearly doubled to approximately 55 million from 2000 to 2020, the need for such innovative solutions is increasingly urgent. Learn more about how AKM’s technology produces quality data to power the next generation of AgeTech. The AKM media kit includes photos of the technologies.

Previous Post

Nutraceuticals 2025 takes position on international trade fair calendar, with fair slated for 5th and 6th March at new venue

Next Post

Scalability and therapeutic potential of induced pluripotent reprogramming and neural induction using small molecules

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post

Scalability and therapeutic potential of induced pluripotent reprogramming and neural induction using small molecules

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In